ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 2.
(2025) Journal of Crohn’s & colitis — Vol. 19, n° 7, p. jjaf107 [1-30] (2025)
Files
2025_Yanai_J_Crohns_Colitis.pdf
Restricted Access - Adobe PDF
- 1.81 MB
Details
- Authors
Yanai, Henit 
Allocca, Mariangela Burisch, Johan
- Abstract
- Inflammatory bowel disease (IBD), which includes Crohn’s disease (CD) and ulcerative colitis (UC), requires meticulous diagnostic and monitoring protocols to optimize patient outcomes. This document synthesizes key advancements and recommendations for clinical indices, endoscopic scoring, imaging, histological assessment, and tools for evaluating IBD disability. Emphasizing validated, reproducible methods aligns with the ongoing evolution of precision medicine in IBD care, including training. The methodology of the guidelines update process is described in part 1.
- Affiliations
Citations
Yanai, H., Feakins, R., Allocca, M., Burisch, J., Ellul, P., Iacucci, M., Maaser, C., Zilli, A., Zidar, N., Wilkens, R., Verstockt, B., Vavricka, S., Uzzan, M., Stoker, J., Scharitzer, M., Rubin, D., Rosini, F., Rimola, J., van Rheenen, P., et al. (2025). ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 2. Journal of Crohn’s & colitis, 19(7), jjaf107 [1-30]. https://doi.org/10.1093/ecco-jcc/jjaf107 (Original work published 2025)